VARIZIG

Indicated For

varicella zoster virus (VZV) post-exposure prophylaxis

About This Medication

# Varizig Patient Assistance Program: How to Get Varicella Zoster Immune Globulin at Low or No Cost ## About Varizig Varizig (varicella zoster immune globulin) is a prescription medication used to prevent chickenpox in people at high risk for severe disease who have been exposed to the varicella-zoster virus. It works by providing your body with antibodies that protect against chickenpox infection. Varizig is given as an injection and must be administered as soon as possible after exposure to chickenpox or shingles, ideally within 10 days. Varizig is recommended for high-risk individuals including immunocompromised children and adults, newborns of mothers with chickenpox, premature infants, pregnant women without immunity, and others who cannot receive the varicella vaccine. Your healthcare provider will determine if Varizig is appropriate for your situation. ## Who Qualifies for This Program The Varizig Patient Assistance Program helps uninsured and underinsured patients access this medication at reduced or no cost. You may qualify if you: - Have no prescription drug coverage, including those without Medicare Part D coverage - Meet the income eligibility requirements (see Income Eligibility section below) - Are a U.S. resident - Have a valid prescription from your healthcare provider - Do not qualify for other insurance programs This program is designed to ensure that cost is not a barrier to receiving this important preventive medication. ## Income Eligibility To qualify for the Varizig Patient Assistance Program, your household income must be at or below **200% of the Federal Poverty Level (FPL)**. The following table shows the 2026 income limits for different household sizes: | Household Size | Annual Income Limit | |---|---| | Individual | $28,860 | | Couple (2 people) | $37,620 | | Family of 3 | $46,380 | | Family of 4 | $55,140 | | Family of 5 | $63,900 | | Family of 6 | $72,660 | | Family of 7 | $81,420 | | Family of 8 | $90,180 | *Note: These figures are based on 2026 Federal Poverty Level guidelines. Income limits may be adjusted annually.* Your household income includes all earnings from employment, Social Security, disability benefits, unemployment benefits, and other sources of income for all household members. ## Insurance Requirements You are eligible for this program if you: - Have **no prescription drug coverage** from any source - Are **uninsured** for prescription medications - Have **Medicare Part D coverage gaps** or cannot afford your copayments - Have insurance that does not cover Varizig If you have any form of prescription insurance coverage, you may still be eligible depending on your specific situation. Contact the program directly at **(855) 898-2446** to discuss your insurance status. ## How to Apply The Varizig Patient Assistance Program accepts applications through multiple methods: ### Step 1: Gather Required Information Before applying, have the following information ready: - Your prescription from your healthcare provider - Proof of income (recent pay stubs, tax returns, or benefit statements) - Proof of U.S. residency - Insurance information (if applicable) - Your Social Security number or tax ID ### Step 2: Contact the Program Reach out to the Varizig Patient Assistance Program: - **Phone:** (855) 898-2446 - **Hours:** Available to answer questions about eligibility and the application process Program representatives can help you determine eligibility, answer questions about the application, and guide you through the process. ### Step 3: Complete Your Application You can apply through multiple methods. When you call, the program representative will explain all available options and help you choose the method that works best for you. Be prepared to provide: - Your medical history and reason for needing Varizig - Household income information - Current insurance status - Your healthcare provider's contact information ### Step 4: Submit Documentation Provide all required documentation to support your application. Keep copies for your records. ### Step 5: Await Approval The program will review your application and notify you of the decision. ## Timeline and Medication Delivery While specific processing times are not publicly listed, the program works to process applications as quickly as possible. Since Varizig must be administered within 10 days of chickenpox exposure, it is important to apply immediately upon exposure and prescription. Once approved, the program will coordinate with your healthcare provider or pharmacy to ensure you receive your medication. Contact the program at **(855) 898-2446** for specific information about delivery timelines for your situation. ## What If Your Application Is Denied? If your application is denied, you have options: 1. **Request clarification** - Contact the program to understand why your application was denied 2. **Appeal the decision** - Ask about the appeals process and reapplication procedures 3. **Explore alternatives** - Discuss other assistance programs with your healthcare provider or social worker 4. **Contact patient advocacy organizations** - Organizations focused on immunocompromised patients or rare diseases may have additional resources Do not delay seeking medical care while exploring these options. If you have been exposed to chickenpox, contact your healthcare provider immediately. ## Frequently Asked Questions For additional questions about the program, call **(855) 898-2446**. Program staff can provide personalized assistance based on your specific circumstances. ## Important Disclaimer This guide provides general information about the Varizig Patient Assistance Program. Program details, eligibility requirements, and benefits may change. For the most current and accurate information, contact the program directly at **(855) 898-2446** or speak with your healthcare provider. This information is not a guarantee of coverage or approval. Each application is reviewed individually based on current program guidelines and eligibility criteria.

Program information last verified: March 30, 2026